Possible sertraline-induced extrapyramidal adverse effects in an adolescent
Open Access
- 1 May 2016
- journal article
- Published by Informa UK Limited in Neuropsychiatric Disease and Treatment
- Vol. ume 12, 1127-1129
- https://doi.org/10.2147/ndt.s106562
Abstract
Possible sertraline-induced extrapyramidal adverse effects in an adolescent Lian-fang Wang,1 Jin-wen Huang,1 Si-yang Shan,2 Jia-hong Ding,3 Jian-bo Lai,1,2 Yi Xu,1,4 Shao-hua Hu1,4 1Department of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, 2Faculty of Clinical Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of China; 3Department of Psychology, University of Hong Kong, Pokfulam, Hong Kong; 4The Key Laboratory of Mental Disorder’s Management in Zhejiang Province, National Clinical Research Center for Mental Health Disorders, Hangzhou, Zhejiang, People’s Republic of China Sertraline has been considered to be a relatively safe selective serotonin reuptake inhibitor for adolescents for a long time. We report herein a case of a 16-year-old Chinese boy with depression who experienced extrapyramidal-like effects, for example, facial spasm, upper limb dystonia, akathisia, and other disturbed behaviors, while being treated with sertraline 200 mg per day. His movement symptoms were significantly alleviated after the discontinuation of sertraline and the administration of scopolamine. This finding indicates that albeit infrequent, sertraline may cause severe extrapyramidal symptoms in adolescent patients, suggesting that clinicians should be alert to the neurological side effects of sertraline in young patients. Keywords: adolescents, selective serotonin reuptake inhibitors, sertraline, extrapyramidal symptomsKeywords
This publication has 10 references indexed in Scilit:
- Extrapyramidal symptoms associated with antidepressants-A review of the literature and an analysis of spontaneous reports2010
- Neurological complications of psychiatric drugs: clinical features and managementHuman Psychopharmacology: Clinical and Experimental, 2007
- The Frequency of Reversible Parkinsonism and Cognitive Decline Associated with Valproate Treatment: A Study of 364 Patients with Different Types of EpilepsyEpilepsia, 2006
- Risk Factors for Extrapyramidal Symptoms During Treatment With Selective Serotonin Reuptake Inhibitors, Including Cytochrome P-450 Enzyme, and Serotonin and Dopamine Transporter and Receptor PolymorphismsJournal of Clinical Psychopharmacology, 2006
- Rabies: recent developmentsResearch in Veterinary Science, 2002
- [Dementia and extrapyramidal problems caused by long-term valproic acid].2001
- Extrapyramidal adverse effects associated with sertralineProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1998
- Extrapyramidal Symptoms Associated With Cyclic Antidepressant TreatmentJournal of Clinical Psychopharmacology, 1997
- [Extrapyramidal disorders following sertraline use; experiences with a new selective antidepressant].1996
- Serotonin-dopamine interaction and its relevance to schizophreniaAmerican Journal of Psychiatry, 1996